AccScience Publishing / GPD / Online First / DOI: 10.36922/gpd.3928
Submit to GPD
Cite this article
14
Download
472
Views
Journal Browser
Volume | Year
Issue
Search
Forthcoming Issue
Current Issue
View All
News and Announcements
View All
ORIGINAL RESEARCH ARTICLE

Genetic association of regulatory single nucleotide variants in GSTA1 and SULT1A1 with cigarette smoke-related lung cancer in an eastern Indian population

Arpan Saha1 ,  Madhurima Sinha1 ,  Susweta Roy1 ,  Debmalya Sengupta1 ,  Souradeep Banerjee1 ,  Ritabrata Mitra2 ,  Abhijit Sarkar3 ,  Tamohan Chaudhuri3 ,  Gautam Bhattacharjee3 ,  Somsubhra Nath4 ,  Susanta Roychoudhury5 ,  Mainak Sengupta1*
Show Less
1 Department of Genetics, Faculty of Genetics, University of Calcutta, Kolkata, West Bengal, India
2 Department of Chest medicine, IPGME&R, Kolkata, West Bengal, India
3 Department of Radiation Oncology, Saroj Gupta Cancer Centre and Research Institute, Thakurpukur, West Bengal, India
4 Institute of Health Sciences, Presidency University, Kolkata, West Bengal, India
5 Department of Molecular Genetics, CSIR-Indian Institute of Chemical Biology (TRUE Campus), Kolkata, West Bengal, India
GPD 2024, 3(3), 3928 https://doi.org/10.36922/gpd.3928
Submitted: 13 June 2024 | Accepted: 31 August 2024 | Published: 24 September 2024
© 2024 by the Author(s). This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution 4.0 International License ( https://creativecommons.org/licenses/by/4.0/ )
Download PDF
Cite
XML
Abstract

The differential expression of genes involved in xenobiotic metabolism and DNA repair has been implicated in the etiology of cigarette smoke-related lung cancer. Our research group has previously identified 22 gene expression-correlated DNAse hypersensitive sequence-single nucleotide variants (SNVs) with regulatory potential to modulate the transcription of seven xenobiotic metabolisms and seven DNA repair genes, thereby contributing to individual susceptibility to lung cancer. In this study, we evaluated the genetic association between lung cancer and two regulatory SNVs (rSNVs) from the list of 22, namely, rs2207950 (A/G) and rs743590 (G/A), which modulate the expression of the xenobiotic metabolism genes GSTA1 and SULT1A1, respectively. A polymerase chain reaction-restriction fragment length polymorphism-based association study was conducted among lung cancer patients exposed to cigarette smoke and healthy smoker controls from an eastern Indian population. A risk genotype AA of GSTA1 rs2207950, with predictive potential, was significantly over-represented among the patients. This genotype is known to cause lower expression of GSTA1 compared to the other two genotypes, potentially leading to reduced efficiency in clearing cigarette smoke-associated xenobiotics, thereby contributing to lung cancer development. Identifying such rSNVs in specific populations can contribute to the development of tailored therapies based on precision medicine, as well as inform efficient legislation governing tobacco use and genetic counseling.

Keywords
Cigarette smoke
Lung cancer
Xenobiotic metabolism
Regulatory single nucleotide variant
Funding
The study was funded by the Departmental BI grant, Department of Genetics, University of Calcutta (grant no.: 97).
Conflict of interest
The authors declare no conflicts of interest.
References
  1. Singh N, Agrawal S, Jiwnani S, et al. Lung cancer in India. J Thorac Oncol. 2021;16(8):1250-1266. doi: 10.1016/j.jtho.2021.02.004

 

  1. United States. Public Health Service. Office of the Surgeon General. How Tobacco Smoke Causes Disease : The Biology and Behavioral Basis for Smoking-Attributable Disease : A Report of the Surgeon General. U.S: Department of Health and Human Services, Public Health Service, Office of the Surgeon General; 2010.

 

  1. Department of Health and Human Services. The Health Consequences of Smoking - 50 Years of Progress: A Report of the Surgeon General. Available from: https://www.cdc.gov/ tobacco [Last accessed on 2024 Sep 23].

 

  1. Mathur P, Sathishkumar K, Chaturvedi M, et al. Cancer Statistics, 2020: Report from national cancer registry programme, India. JCO Glob Oncol. 2020;6:1063-1075. doi: 10.1200/GO.20.00122

 

  1. Schwartz AG. Genetic epidemiology of cigarette smoke-induced lung disease. Proc Am Thorac Soc. 2012;9:22-26. doi: 10.1513/pats.201106-037MS

 

  1. Ankathil R. Tobacco, Genetic Susceptibility and Lung Cancer. Vol. 2010. Available from: https://www.la-press.com [Last accessed on 2024 Sep 23].

 

  1. Byun J, Han Y, Li Y, et al. Cross-ancestry genome-wide meta-analysis of 61,047 cases and 947,237 controls identifies new susceptibility loci contributing to lung cancer. Nat Genet. 2022;54(8):1167-1177. doi: 10.1038/s41588-022-01115-x

 

  1. Sato M, Shames DS, Gazdar AF, Minna JD. A translational view of the molecular pathogenesis of lung cancer. J Thorac Oncol. 2007;2(4):327-343. doi: 10.1097/01.JTO.0000263718.69320.4c

 

  1. Sun S, Schiller JH, Spinola M, Minna JD. New molecularly targeted therapies for lung cancer. J Clin Invest. 2007;117(10):2740-2750. doi: 10.1172/JCI31809

 

  1. Long E, Patel H, Byun J, Amos CI, Choi J. Functional studies of lung cancer GWAS beyond association. Hum Mol Genet. 2022;31(R1):R22-R36. doi: 10.1093/hmg/ddac140

 

  1. Van Dyck E, Nazarov PV, Muller A, et al. Bronchial airway gene expression in smokers with lung or head and neck cancer. Cancer Med. 2014;3(2):322-336. doi: 10.1002/cam4.190

 

  1. Hammouz RY, Kostanek JK, Dudzisz A, Witas P, Orzechowska M, Bednarek AK. Differential expression of lung adenocarcinoma transcriptome with signature of tobacco exposure. J Appl Genet. 2020;61(3):421-437. doi: 10.1007/s13353-020-00569-1

 

  1. Bozhilov YK, Downes DJ, Telenius J, et al. A gain-of-function single nucleotide variant creates a new promoter which acts as an orientation-dependent enhancer-blocker. Nat Commun. 2021;12(1):3806. doi: 10.1038/s41467-021-23980-6

 

  1. Kotnis A, Sarin R, Mulherkar R. Genotype, phenotype and cancer: Role of low penetrance genes and environment in tumour susceptibility. J Biosci. 2005;30:93-102. doi: 10.1007/BF02705154

 

  1. Pfeifer GP, Denissenko MF, Olivier M, Tretyakova N, Hecht SS, Hainaut P. Tobacco smoke carcinogens, DNA damage and p53 mutations in smoking-associated cancers. Oncogene. 2002;21:7435-7451. doi: 10.1038/sj.onc.1205803

 

  1. Leanderson P, Tagesson C. Cigarette smoke-induced DNA damage in cultured human lung cells: Role of hydroxyl radicals and endonuclease activation. Chem Biol Interact. 1992;81:197-208. doi: 10.1016/0009-2797(92)90034-i

 

  1. Sengupta D, Mukhopadhyay P, Banerjee S, et al. Identifying polymorphic cis-regulatory variants as risk markers for lung carcinogenesis and chemotherapy responses in tobacco smokers from eastern India. Sci Rep. 2023;13(1):4019. doi: 10.1038/s41598-023-30962-9

 

  1. Jensen A, Løhr M, Eriksen L, et al. Influence of the OGG1 Ser326Cys polymorphism on oxidatively damaged DNA and repair activity. Free Radic Biol Med. 2012;52(1):118-125. doi: 10.1016/j.freeradbiomed.2011.09.038

 

  1. Suzuki T, Shibata T, Takaya K, et al. Regulatory nexus of synthesis and degradation deciphers cellular Nrf2 expression levels. Mol Cell Biol. 2013;33(12):2402-2412. doi: 10.1128/mcb.00065-13

 

  1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394-424. doi: 10.3322/caac.21492

 

  1. Molecular Cloning this is a Free Sample of Content from Molecular Cloning: A Laboratory Manual. Click Here for More Information or to Buy the Book. 4th ed; 2012. Available from: https://www.cshlpress.org [Last accessed on 2024 Sep 23].

 

  1. Spivack SD, Hurteau GJ, Fasco MJ, Kaminsky LS. Phase I and II carcinogen metabolism gene expression in human lung tissue and tumors. Clin Cancer Res. 2003;9:6002-6011.

 

  1. Anttila S, Hietanen E, Vainio H, et al. Smoking and peripheral type of cancer are related to high levels of pulmonary cytochrome p450ia in lung cancer patients. Int J Cancer. 1991;47:681-685. doi: 10.1002/ijc.2910470509

 

  1. Degtyareva AO, Antontseva EV, Merkulova TI. Regulatory SNPs: Altered transcription factor binding sites implicated in complex traits and diseases. Int J Mol Sci. 2021;22(12):6454. doi: 10.3390/ijms22126454

 

  1. Hayes JD, Flanagan JU, Jowsey IR. Glutathione transferases. Annu Rev Pharmacol Toxicol. 2005;45:51-88. doi: 10.1146/annurev.pharmtox.45.120403.095857

 

  1. Townsend DM, Tew KD. The role of glutathione-S-transferase in anti-cancer drug resistance. Oncogene. 2003;22(47):7369-7375. doi: 10.1038/sj.onc.1206940

 

  1. Holley SI, Fryer AA, Haycock JW, Grubb SEW, Strange RC, Hoban PR. Differential effects of glutathione S-transferase pi (GSTP1) haplotypes on cell proliferation and apoptosis. Carcinogenesis. 2007;28(11):2268-2273. doi: 10.1093/carcin/bgm135

 

  1. Liu X, Sui X, Zhang C, et al. Glutathione S-transferase A1 suppresses tumor progression and indicates better prognosis of human primary hepatocellular carcinoma. J Cancer. 2020;11(1):83-91. doi: 10.7150/jca.36495

 

  1. Adnan H, Quach H, MacIntosh K, Antenos M, Kirby GM. Low levels of GSTA1 expression are required for Caco-2 cell proliferation. PLoS One. 2012;7(12):e51739. doi: 10.1371/journal.pone.0051739

 

  1. Liu Z, Wang M, Zhang C, Zhou S, Ji G. Molecular functions of ceruloplasmin in metabolic disease pathology. Diabetes Metab Syndr Obes. 2022;15:695-711. doi: 10.2147/DMSO.S346648

 

  1. Mlakar V, Curtis PHD, Armengol M, et al. The analysis of GSTA1 promoter genetic and functional diversity of human populations. Sci Rep. 2021;11(1):5038. doi: 10.1038/s41598-021-83996-2

 

  1. Ahn J, Gammon MD, Santella RM, et al. Effects of glutathione S-transferase A1 (GSTA1) genotype and potential modifiers on breast cancer risk. Carcinogenesis. 2006;27(9):1876-1882. doi: 10.1093/carcin/bgl038

 

  1. Pan XD, Yang ZP, Tang QL, et al. Expression and function of GSTA1 in lung cancer cells. Asian Pac J Cancer Prev. 2014;15(20):8631-8635. doi: 10.7314/APJCP.2014.15.20.8631

 

  1. Lilla C, Risch A, Kropp S, Chang-Claude J. Open access SULT1A1 genotype, active and passive smoking, and breast cancer risk by age 50 years in a German case–control study. Breast Cancer Res. 2005;7:R229-R237. doi: 10.1186/bcr976

 

  1. Zhang S, Li M, Ji H, Fang Z. Landscape of transcriptional deregulation in lung cancer. BMC Genomics. 2018;19(1):435. doi: 10.1186/s12864-018-4828-1

 

  1. Shendre A, Irvin MR, Wiener H, et al. Local ancestry and clinical cardiovascular events among African Americans from the atherosclerosis risk in communities study. J Am Heart Assoc. 2017;6:e004739. doi: 10.1161/JAHA.116.004739

 

  1. Patel SD, Le-Niculescu H, Koller DL, et al. Coming to grips with complex disorders: Genetic risk prediction in bipolar disorder using panels of genes identified through convergent functional genomics. Am J Med Genet B Neuropsychiatr Genet. 2010;153(4):850-877. doi: 10.1002/ajmg.b.31087

 

  1. Ng L, Nichols K, O’Rourke K, Maslen A, Kirby GM. Repression of human GSTA1 by interleukin-1β is mediated by variant hepatic nuclear factor-1C. Mol Pharmacol. 2007;71(1):201-208. doi: 10.1124/mol.106.028563

 

  1. Santos SS, Koifman RJ, Ferreira RM, et al. SULT1A1 genetic polymorphisms and the association between smoking and oral cancer in a case-control study in Brazil. Front Oncol. 2012;2:183. doi: 10.3389/fonc.2012.00183

 

  1. Jiang Y, Zhou L, Yan T, Shen Z, Shao Z, Lu J. Association of sulfotransferase SULT1A1 with breast cancer risk: A meta-analysis of case-control studies with subgroups of ethnic and menopausal statue. J Exp Clin Cancer Res. 2010;29(1):101. doi: 10.1186/1756-9966-29-101

 

  1. Huang X, Cao M, Wang L, et al. Expression of sulfotransferase SULT1A1 in cancer cells predicts susceptibility to the novel anticancer agent NSC-743380. Oncotarget. 2014;6:345-354. doi: 10.18632/oncotarget.2814

 

  1. Kim SS, Hudgins AD, Yang J, et al. A comprehensive integrated post-GWAS analysis of Type 1 diabetes reveals enhancerbased immune dysregulation. PLoS One. 2021;16(9):e0257265. doi: 10.1371/journal.pone.0257265
Share
Back to top
Gene & Protein in Disease, Electronic ISSN: 2811-003X Published by AccScience Publishing
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here
Accept